<--- Back to Details
First PageDocument Content
Clinical research / Pharmacology / Drug safety / Pharmaceutical industry / Adverse event / Institutional review board / Food and Drug Administration / National Institutes of Health / Adverse effect / Medicine / Health / Research
Date: 2014-03-10 08:07:42
Clinical research
Pharmacology
Drug safety
Pharmaceutical industry
Adverse event
Institutional review board
Food and Drug Administration
National Institutes of Health
Adverse effect
Medicine
Health
Research

SOP 16. REPORTING REQUIREMENTS FOR UNANTICIPATED PROBLEMS,

Add to Reading List

Source URL: ohsr.od.nih.gov

Download Document from Source Website

File Size: 1,09 MB

Share Document on Facebook

Similar Documents

Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute

DocID: 1vqc4 - View Document

SCIENCE & TECHNOLOGY POLICY IN STITUTE Technology Development at the National Institutes of Health (NIH): Summary Report Brian L. Zuckerman

DocID: 1v9kv - View Document

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Heart, Lung, and Blood Institute (NHLBI)

DocID: 1v3b2 - View Document

Conference Organizers James Prestegard, CFG and University of Georgia Michael Tiemeyer, CFG and University of Georgia John Hanover, CFG and National Institutes of Health Joyce Taylor-Papadimitriou, CFG and King’s Colle

DocID: 1v07l - View Document

Nematode sperm motility* Harold E. Smith§ National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD, USA Table of Contents

DocID: 1uVU8 - View Document